Familial hypercholesterolaemia trials in Israel

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies

  Where

  Jerusalem, Ramat Gan

  Age

  2 years to 100 years

  People

  195 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT05682378
• Phase 1Taking people
  A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

  Where

  Rehovot

  Age

  18 years to 70 years

  People

  85 worldwide

  Run by

  Verve Therapeutics, Inc.

  See details and how to joinNCT06164730
• Phase 3Not yet taking people in Israel
  Long-Term Efficacy and Safety of Lerodalcibep in Children and Adolescents With Familial Hypercholesterolemia

  Where

  Jerusalem

  Age

  6 years to 17 years

  People

  150 worldwide

  Run by

  LIB Therapeutics LLC

  See details and how to joinNCT07775339 · EU 2026-528022-38-00
• Phase 3Enrolling by invitation
  Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH

  Where

  Jerusalem

  Age

  6 years to 17 years

  People

  150 worldwide

  Run by

  LIB Therapeutics LLC

  See details and how to joinNCT07102511 · EU 2025-524214-28-00
• Phase 3Taking people
  Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia

  Where

  Jerusalem, Ramat Gan

  Age

  6 years to 11 years

  People

  60 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06597019